Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Oncotarget|March 3, 2016
CD40-activated B cells induce anti-tumor immunity in vivoKerstin Wennhold, Tanja M Weber, Nela Klein-Gonzalez, et al.The Journal of Infection|December 18, 2021
T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment optionSibylle C Mellinghoff, Martin Thelen, Christiane Bruns, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2014
Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunityAlexander Shimabukuro-Vornhagen, Shahram Zoghi, Tanja M Liebig, et al.Cancer Immunology Research|August 6, 2017
Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer ImmunotherapyKerstin Wennhold, Martin Thelen, Hans Anton Schlößer, et al.Journal of Leukocyte Biology|August 19, 2016
Antigen-presenting human B cells are expanded in inflammatory conditionsAlexander Shimabukuro-Vornhagen, María García-Márquez, Rieke N Fischer, et al.Cancer Immunology Research|June 22, 2021
CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell ResponsesKerstin Wennhold, Martin Thelen, Jonas Lehmann, et al.Oncotarget|June 3, 2017
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinomaAxel Lechner, Hans Schlößer, Sacha I Rothschild, et al.Journal for Immunotherapy of Cancer|January 5, 2023
Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cellsMartin Thelen, Diandra Keller, Jonas Lehmann, et al.Leukemia|September 29, 2021
Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphomaMaria A Garcia-Marquez, Martin Thelen, Sarah Reinke, et al.Cancer Immunology, Immunotherapy : CII|October 2, 2020
Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinomaKatharina Leuchte, Elena Staib, Martin Thelen, et al.Pageof 4